First decision: May 12, Article in press: August 8, National Center for Biotechnology Information , U. Journal List World J Gastroenterol v. World J Gastroenterol. Published online Sep Author information Article notes Copyright and License information Disclaimer. Pascale", Naples, Italy. Author contributions: Petruzziello A, Marigliano S, Loquercio G and Cozzolino A acquired the data; Petruzziello A drafted the article and contributed to conception and design; Cacciapuoti C contributed to critical revision for important intellectual content; all authors approved the final version to be published.
Published by Baishideng Publishing Group Inc. All rights reserved. This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers.
This article has been cited by other articles in PMC. Table 1 Global anti-hepatitis C virus prevalence and number of infected individuals all ages.
Open in a separate window. HCV: Hepatitis C virus. Table 2 Regional estimates of hepatitis C virus seroprevalence and viraemia. Table 3 Global prevalence of hepatitis C virus genotypes. Table 4 Regional estimates of hepatitis C virus genotypes. Figure 1. Figure 2. Figure 3. Anti-hepatitis C virus prevalence A and genotype distribution B in America. Figure 4. Anti-hepatitis C virus prevalence A and genotype distribution B in Asia.
Figure 5. Anti-hepatitis C virus prevalence A and genotype distribution B in Australasia. Figure 6. Anti-hepatitis C virus prevalence A and genotype distribution B in Europe.
Research frontiers This manuscript provided the strategies to fight the diffusion of HCV infection worldwide. Innovations and breakthroughs The authors showed us the epidemiological up-date of HCV genotypes. Applications These findings can be used in clinical therapy and prevention strategies. Peer-review This is a pretty good manuscript.
References 1. Viral hepatitis and the Global Burden of Disease: a need to regroup. J Viral Hepat. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
Hepatitis C virus infection. N Engl J Med. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIVinfected patients treated with antiretroviral therapy, collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. Strategies to manage hepatitis C virus HCV disease burden. Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy.
Lavanchy D. The threat to public health of hepatitis C. Res Virol. Hepatitis C: public health strategies. J Hepatol. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. The global burden of hepatitis C. Liver Int. Global burden of disease GBD for hepatitis C. J Clin Pharmacol. Historical epidemiology of hepatitis C virus HCV in selected countries. Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: implications for immune control and therapy.
Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ.
A proposed system for the nomenclature of hepatitis C viral genotypes. Comparison of different HCV viral load and genotyping assays. J Clin Virol. Hepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probes. Clin Chem. Zein NN. Clinical significance of hepatitis C virus genotypes.
Clin Microbiol Rev. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity.
J Gen Virol. HCV genotyping by three methods: analysis of discordant results based on sequencing. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: epidemiological applications.
J Med Virol. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. The origin of hepatitis C virus genotypes. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med. Simmonds P. The origin and evolution of hepatitis viruses in humans. Genetic history of hepatitis C virus in East Asia.
J Virol. J Clin Microbiol. Colonial history and contemporary transmission shape the genetic diversity of hepatitis C virus genotype 2 in Amsterdam. Institute for Health Metrics and Evaluation. GBD common questions.
Seattle, Washington: Institute for health Metrics and Evaluation; GBD protocol. GBD Study. Global burden of diseases, injuries and risk factors study operations manual final draft, January Accessed Cited by: 15 articles PMID: Lancet Glob Health , 5 10 :ee, 01 Oct Contact us.
Europe PMC requires Javascript to function effectively. Recent Activity. Search life-sciences literature Over 39 million articles, preprints and more Search Advanced search. This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy. Abstract Available from publisher site using DOI. A subscription may be required. Madhava V 1 ,.
Christine Burgess Search articles by 'Christine Burgess'. Burgess C ,. Ernest Drucker Search articles by 'Ernest Drucker'. Drucker E.
Affiliations 1 author 1. Share this article Share with email Share with twitter Share with linkedin Share with facebook. Sub-Saharan Africa is of great interest because it is reported to have the highest HCV prevalence rate 5. In our review of the published literature we found consistent evidence of high HCV prevalence in many countries of Africa. Full text links Read article at publisher's site DOI : References Articles referenced by this article 31 Global surveillance and control of hepatitis C.
Epidemiology of hepatitis C Alter Acute hepatitis Hoofnagle Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger.
Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma. A method for the detection and confirmation of antibodies to hepatitis C virus in dried blood spots. Screening for viral markers in volunteer and replacement blood donors in West Africa. Conclusion The paucity of available information indicates that hepatitis C is still a neglected disease in many countries.
Competing interests The authors declare no competing interests. References 1. Centers for Disease Control and Prevention. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. Williams R. Global challenges in liver disease. Sy T, Jamal MM. Epidemiology of hepatitis C virus HCV infection. Int J Med Sci. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.
Lancet Infect Dis. Weekly Epidemiological Record. The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach.
Mol Biol Evol. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Global burden of disease GBD for hepatitis C. J Clin Pharmacol. Maheshwari A, Thuluvath PJ. Management of acute hepatitis C. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.
Public Health. Is sexual contact a major mode of hepatitis C virus transmission? Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. Caring for pregnant women and newborns with hepatitis B or C. Am Fam Physician. Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Evidence for high genetic diversity and longterm endemicity of hepatitis C virus genotypes 1 and 2 in West Africa.
J Med Virol. Eur J Gastroenterol Hepatol. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission.
Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol. Pearlman BL. Clinical Infectious Diseases. Hepatitis C virus infection.
N Engl J Med. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Current therapy for hepatitis C. Int J Colorectal Dis. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. The long-term outcomes of patients with compensated hepatitis C virus- related cirrhosis and history of parenteral exposure in the United States. Seeff LB. Natural history of chronic hepatitis C. Pathogenesis, natural history, treatment, and prevention of hepatitis C.
Pawlotsky JM. Molecular diagnosis of viral hepatitis. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C - Hepatitis Interventional Therapy Group.
Kim AI, Saab S. Treatment of hepatitis C. The American journal of medicine. Diagnosis, management, and treatment of hepatitis C: An update. Sandeep M, Dhawan VK. In: Katz J, editor.
0コメント